10.07.2019 • News

Oxea Selects Oberhausen for Carboxylic Acids

Following an “extensive” selection process, German oxo-chemicals company Oxea has chosen Oberhausen as the site for its proposed world-scale carboxylic acids plant.

Oxea Selects Oberhausen for Carboxylic Acids
Oxea Selects Oberhausen for Carboxylic Acids

“Our Oberhausen manufacturing facility offers definitive advantages in speed of construction and integration into our existing production network,” explained chief operating officer Oliver Borgmeier.

The facility – the sixth in Oxea’s global manufacturing network – will double current capacity for isononanoic acid and raise its total carboxylic acids output by more than 30% when it comes on stream by the end of 2021.

“With our new plant, we intend to substantially improve the supply situation for isononanoic acid. Oxea’s increased capacity will further enhance the flexibility of our production platforms, allowing our customers to grow their businesses across the whole acid portfolio,” said Kyle Hendrix, global commercial director for carboxylic acids and derivatives. “Oxea will additionally set up its own dedicated logistics hub in Asia to support the growth and agility of the Asian market.”

The company revealed last January that it was studying the feasibility of a new plant as well as implementing steps to further improve and debottleneck its manufacturing processes at its five existing units during 2020 in order to meet rising demand.

Carboxylic acids are used in the production of synthetic lubricants and as building blocks for the animal feed industry.

 

Company

Logo:

Oxea

Rheinpromenade 4a
40789 Monheim am Rhein
Germany

Company contact







Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

March 24, 2026 | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read